Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Moderate antiproliferative effect of the antifolate CB3717 in the BN myeloid leukaemia model.

× No keyword cloud information.

12 in total

1. Phase II study of a novel antifolate, N10-propargyl-5,8 dideazafolic acid (CB3717), in malignant mesothelioma.

Authors: B M Cantwell; M Earnshaw; A L Harris
Journal: Cancer Treat Rep Date: 1986-11

2. A method for performing deoxyuridine suppression tests on microtitre plates.

Authors: J H Matthews; S N Wickramasinghe
Journal: Clin Lab Haematol Date: 1986

3. A potent antitumour quinazoline inhibitor of thymidylate synthetase: synthesis, biological properties and therapeutic results in mice.

Authors: T R Jones; A H Calvert; A L Jackman; S J Brown; M Jones; K R Harrap
Journal: Eur J Cancer Date: 1981-01 Impact factor: 9.162

4. Interaction of chemotherapeutic agents with methotrexate and 5-fluorouracil and its effect on de novo DNA synthesis.

Authors: H W Bruckner; C Schreiber; S Waxman
Journal: Cancer Res Date: 1975-03 Impact factor: 12.701

5. Pharmacokinetics of the thymidylate synthase inhibitor N10-propargyl-5,8-dideazafolic acid (CB3717) in the mouse.

Authors: D R Newell; D L Alison; A H Calvert; K R Harrap; M Jarman; T R Jones; M Manteuffel-Cymborowska; P O'Connor
Journal: Cancer Treat Rep Date: 1986-08

6. A phase I evaluation of the quinazoline antifolate thymidylate synthase inhibitor, N10-propargyl-5,8-dideazafolic acid, CB3717.

Authors: A H Calvert; D L Alison; S J Harland; B A Robinson; A L Jackman; T R Jones; D R Newell; Z H Siddik; E Wiltshaw; T J McElwain
Journal: J Clin Oncol Date: 1986-08 Impact factor: 44.544

7. The clinical pharmacokinetics of the novel antifolate N10-propargyl-5,8-dideazafolic acid (CB 3717).

Authors: D L Alison; D R Newell; C Sessa; S J Harland; L I Hart; K R Harrap; A H Calvert
Journal: Cancer Chemother Pharmacol Date: 1985 Impact factor: 3.333

8. Enhanced therapeutic effect of methotrexate in experimental rat leukemia after inactivation of cobalamin (vitamin B12) by nitrous oxide.

Authors: A C Kroes; J Lindemans; M Schoester; J Abels
Journal: Cancer Chemother Pharmacol Date: 1986 Impact factor: 3.333

9. Activity of the new antifolate N10-propargyl-5,8-dideazafolate and its polyglutamates against human dihydrofolate reductase, human thymidylate synthetase, and KB cells containing different levels of dihydrofolate reductase.

Authors: Y C Cheng; G E Dutschman; M C Starnes; M H Fisher; N T Nanavathi; M G Nair
Journal: Cancer Res Date: 1985-02 Impact factor: 12.701

10. Inhibition of the growth of human hepatocellular carcinoma in vitro and in athymic mice by a quinazoline inhibitor of thymidylate synthase, CB3717.

Authors: N J Curtin; A L Harris; O F James; M F Bassendine
Journal: Br J Cancer Date: 1986-03 Impact factor: 7.640